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We	   present	   recent	   investigation	   by	   means	   of	   nanoscale	   techniques	   on	   biocompatible	   linear	  
polyamidoamines	  with	  amphoteric	  character,	  namely	  AGMA1	  [1]	  and	  ARGO7	  [2].	  These	  polymers	  
have	  been	  shown	  of	  extremely	  promising	  and	  already	  proved	  medical	   interest,	   comprising	   their	  
strong	   protection	   actions	   against	   virus	   infection,	   mainly	   papilloma	   and	   herpes	   [1-­‐5]	   and	   the	  
extremely	   low	  toxicity	  of	   their	  DNA	  complexes,	  with	  respect	  to	  other	  used	  polymers	  such	  as	  PEI	  
and	   protamine,	   applied	   in	   nanovector	   design	   for	   gene	   delivery.	   Our	   studies	   focus	   on	   the	  most	  
important	  of	  these	  polymers,	  AGMA1,	  a	  prevailingly	  cationic	  4-­‐aminobutylguanidine-­‐deriving	  PAA,	  
whose	  mechanism	  of	  action	   is	   so	   far	  not	   fully	  understood.	  The	  current	  understanding	   is	   that	   its	  
interaction	   with	   cell	   surfaces	   by	   means	   of	   glycosaminoglycans	   (HSPG)	   has	   a	   major	   role	   in	   its	  
protective	   action	   against	   viruses.	   Yet,	   AGMA1	   is	   active	   also	   against	   HPV-­‐31,	  whose	   attachment	  
does	  not	  appear	  to	  be	  dependent	  on	  HSPG	  [4].	  HPV-­‐31,	  whose	  attachment	  does	  not	  appear	  to	  be	  
dependent	  on	  HSPG	  [4].	  Therefore,	  AGMA1	  binds	  other	  (as	  yet	  unidentified)	  receptors	  on	  the	  cell	  
surface.	   As	   the	   known	   recipient	   is	   the	   HS	   carbohydrate	   moiety,	   other	   sugars	   rich	   membrane	  
components	   have	   been	  proposed	   as	   probable	  AGMA1	   target.	   Therefore,	   to	   shed	   a	   light	   on	   the	  
mechanism	   of	   interaction	   of	   the	   polymer	  with	   sugar	   containing	   biologically	   relevant	  molecules,	  
not	   HS,	   we	   have	   investigated	   AGMA1	   in	   interaction	   with	   glycophyngolipids,	   Specifically,	   we	  
studied	   multicomponent	   symmetric	   vesicles	   enriched	   in	   ganglioside	   GM1	   [6]	   built	   to	   mimic	  
biological	   membrane	   domains,	   in	   the	   presence	   of	   AGMA1,	   At	   physiological	   pH,	   electrostatic	  
effects	   should	  be	   the	   relevant	   interactions	  between	  GM1	  and	  AGMA1.	  Taking	  advantage	  of	   the	  
same	   mechanism	   we	   investigated	   the	   possibility	   of	   building	   lipid	   based	   core-­‐shell	   particles	   to	  
vehiculate	   AGMA1/siRNA	   complexes.	  Moreover,	   since	   it	   is	   probable	   that	   AGMA1	   interacts	  with	  
the	  barrier	  of	  mucus	  which	  cover	  the	  involved	  tissue	  we	  have	  extended	  our	  investigations	  also	  to	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Figure	  1.	  Artificial	  model	  membrane	  enriched	  in	  ganglioside	  in	  
interaction	  with	  AGMA1.	  Coated	  vesicle	  and	  multilayer	  vesicle	  
are	  formed	  in	  different	  conditions.	  
